Lineage Cell Therapeutics (LCTX) Q1 2026 Earnings

5MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.13
-0.09
-0.04
0

Details

Expected EPS
-0.042857
Actual EPS
0.004
Surprise EPS
0.05
Surprise Percent
+109.33%

Description

Lineage Cell Therapeutics (LCTX) has reported earnings of 0.004 per share for Q1 2026.

0 Comments

Share your thoughts